ERS Publications Podcasts

As part of the April 2023 issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Alvar Agusti (Hospital Clinic, Barcelona, Spain)about the new Global Initiative for Chronic Obstructive Lung Disease (GOLD)report.

"We need to be cognisant of the new, less common risk factors that are associated with various cancers" ERS Monograph early career representative Holly Keir talks to co-Guest Editor Kwun M. Fong about the Monograph on Lung Diseases and Cancer. In a conversation covering the bidirectional relationship between cancer and lung disease, the impact of climate change, cancer's relationship with vaping and the pulmonary effects of new cancer treatments, Kwun explains why this Monograph is relevant to all in respiratory medicine, from bench to bedside.

"This condition is really overlooked. The point of the Monograph is that it should, hopefully, raise awareness." In the latest instalment of the ERS Monograph podcast series, Editorial Board member Holly Keir talks to James H. Hull, one of the Guest Editors of the Monograph on Complex Breathlessness. In a conversation that focuses on the need for robust investigation when faced with unexplained breathlessness, James and Holly discuss: the use of physiological tests and CPET for assessment; postural tachycardia syndrome and autonomic dysfunction; the importance of developing breathlessness clinics in the future; and therapy-based treatments, such as physiotherapy and speech and language therapy.

“One of the major motivations of this Monograph was to involve several specialities in order to provide the broadest overview of the manifestations of sarcoidosis” In the latest instalment of the ERS Monograph podcast series, Editorial Board member Sheila Ramjug talks to Francesco Bonella and Daniel Culver, co-Guest Editors of the Monograph on Sarcoidosis. In an engaging conversation about this fascinating, chameleonic disease, Francesco and Daniel discuss multidisciplinary collaboration, advances of the last 10 years, areas of possible underdiagnosis and, importantly, the future. A conversation that really highlights how this Monograph is “an opportunity to grow the field.”

"A one-stop-shop for a better understanding of this important cell and all the diseases associated with it" ERS Monograph early career representative Sheila Ramjug talks to David J. Jackson and Michael Wechsler about their Monograph, Eosinophilic Lung Diseases. In a conversation covering eosinophil types and the way they work, the safety of eosinophil depletion, key chapters and important questions for the future, David and Michael explain why this Monograph is relevant to everyone, both junior and senior physicians and scientists alike.

“Suddenly, I find myself involved in research and clinical care in a disease I hadn’t even heard about 2 ½ years ago” In a conversation that really encapsulates the pandemic rollercoaster we continue to live through, Guest Editors Aurelie Fabre, John Hurst and Sheila Ramjug discuss the importance of the ERS Monograph on COVID-19, providing as it does a comprehensive review of all areas of the disease. This podcast is a fascinating listen for researchers and clinicians from both within and beyond respiratory medicine, and will even appeal to the lay listener. The podcast covers the incentives behind a COVID Monograph, standout chapters, the positives that can be drawn from the pandemic and the importance of collaboration: “a reflection of how much we can achieve when we work as one”.

"People's lives can be changed and [...] the important symptoms they are struggling with can be managed and in many cases, relieved" In the latest instalment of the ERS Monograph podcast series, Editorial Board member Sheila Ramjug talks to Anne Holland, Professor of Physiotherapy at Monash University and Guest Editor of the Monograph on Pulmonary Rehabilitation. Their broad-ranging discussion covers everything from balancing a home life with a career in medicine, to the impact of COVID-19 on implementing pulmonary rehabilitation. Anne talks about the origins of pulmonary rehabilitation, the need to better personalise patient care, and recommends chapters that will help readers understand the patient experience and that provide practical tips on establishing a rehabilitation programme.

"In terms of preventing them coming to your clinic, the only thing we can do is focus on the early years." The lasting impact of respiratory health in the early years, pre-birth and even pre-conception forms the focus of earnest and warm discussion in this latest fascinating Monograph podcast. Ian P. Sinha and Jayesh Mahendra Bhatt, Guest Editors of Respiratory Diseases of the Newborn Infant, talk to Sheila Ramjug about what attracted them to the field, the reasons behind the Monograph’s compilation and its importance to non-paediatric respiratory physicians, the impact of socioeconomic status on lung health and the devastating effects of child poverty.

Marko Nikolic and Brigid Hogan discuss the Monograph on Lung Stem Cells in Development, Health and Disease with Editorial Board member Sheila Ramjug. Featuring a fascinating and inspiring discussion about balancing a career as both a clinician and scientist, Sheila also asks the guest editors why this book is so important to both professions, which chapters they would recommend, new models in stem cell science and what the future holds. Order your print copy of the book at ersbookshop.com or visit books.ersjournals.com to access the book online

ERS Monograph Editorial Board member Dr Sheila Ramjug interviews Guest Editors Dr Sofia Belo Ravara, Dr Paraskevi Katsaounou and Professor Keir Lewis about the latest ERS Monograph, Supporting Tobacco Cessation. In a discussion covering personal interests in the field and more controversial issues, such as e-cigarettes as a stop-smoking device, the Guest Editors demonstrate how this Monograph is not only an interesting read but has a practical application in the clinic.

In this podcast, Dr Sheila Ramjug (member of the ERS Monograph Editorial Board) interviews Guest Editor Dr Johanna Feary and contributing author Professor Mohamed Jeebhay about the latest ERS Monograph on Occupational and Environmental Lung Disease. In an interesting and thought-provoking discussion, Johanna and Mohamed share the reasons for their personal interest in the field, as well as their "must read" Monograph chapters. They also consider weighty issues, such as gender balance in the workplace and its effect, old and new agents causing disease and whether diagnosis of occupational lung disease is improving.

The latest ERS Monograph podcast focuses on the new issue: Cardiovascular Complications of Respiratory Disorders. Editorial Board member Dr Sheila Ramjug asks Guest Editor Professor Miguel Ángel Martínez-García about his career path, what drew him to cardiovascular complications, his experiences of joint working between cardiology and respiratory departments, and the key chapters in the Monograph.

As part of the June issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor Martin Kolb interviews Kevin K. Brown (National Jewish Health, Denver, CO, USA) and Athol U. Wells (Royal Brompton Hospital, London, UK) about analyses of data from the INBUILD and INPULSIS trials suggesting that progressive fibrosing interstitial lung diseases other than idiopathic pulmonary fibrosis have a clinical course similar to IPF.

This second ERS Monograph podcast on pleural disease takes the form of a question and answer session. ERS Monograph Editorial Board member Dr Sheila Ramjug puts your questions to Professor Najib Rahman about the management of pneumothorax and trapped lung, empyema and the RAPID score, as well as AMPLE-2 in daily practice. You can download the Pleural Disease eBook at books.ersjournals.com (ERS members have free access).

As part of the February issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor James Chalmers interviews Peter G. Middleton (University of Sydney, Sydney, Australia) about the European Respiratory Society and the Thoracic Society of Australia and New Zealand’s new statment on the management of reproduction and pregnancy in women with airways diseases published in this issue.

ERS has recorded a special edition podcast to coincide with the forthcoming ERS Monograph on Pleural Disease. Editorial Board member Dr Sheila Ramjug asks how Guest Editors Professor Christian Laursen and Professor Najib Rahman began working in the field, and what the recent significant changes in both pleural disease and thoracic ultrasound have been. They also discuss the rationale behind the Monograph, the key chapters in the book and the upcoming ERS Courses in the area. Listen to the podcast here and visit ersbookshop.com to pre-order your copy of Pleural Disease.

As part of the January issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor James Chalmers interviews Alyn Morice (University of Hull, Hull, UK) about the European Respiratory Society’s new guidelines on the diagnosis and treatment of chronic cough in adults and children published in this issue. Alyn Morice is Chief Editor of ERJ Open Research. Sign up for ERJ Open Research alerts at https://openres.ersjournals.com/alerts

As part of the December issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor Martin Kolb interviews Jørgen Vestbo (ERS Advocacy Council Chair) about the European Respiratory Society's position on tobacco harm reduction published in this issue.

As part of the November issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor James Chalmers interviews Sarah Hiles (University of Newcastle, Callaghan, Australia), Peter Gibson (University of Newcastle, Callaghan, and John Hunter Hospital, New Lambton Heights, Australia) and Guy Brusselle (Ghent University Hospital, Ghent, Belgium, and Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands) about their individual patient data meta-analysis of the use of azithromycin in severe asthma published in this issue.

As part of the July issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor James Chalmers interviews Michael Loebinger (Royal Brompton Hospital and Imperial College London, UK) and Jakko van Ingen (Radboud University Medical Center, Nijmegen, the Netherlands) about five articles on the subject on nontuberculous mycobacteria published in this issue.

As part of the March issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor Martin Kolb interviews Toby Maher (Royal Brompton Hospital and Imperial College London, UK) about two articles in this issue reporting the results of randomised controlled trials in idiopathic pulmonary fibrosis.

As part of the January issue, the European Respiratory Journal presents the latest in its series of podcasts. Section Editor Marc Humbert interviews Nazzareno Galiè (University of Bologna, Bologna, Italy) about a collection of articles in this issue arising from the Sixth World Symposium on Pulmonary Hypertension.

As part of the October issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor James Chalmers interviews David Lederer (Editor-in-Chief, Annals of the American Thoracic Society) about the outcome of a recent discussion among respiratory journal editors on the reporting of causal inference studies.

As part of the September issue, the European Respiratory Journal presents the latest in its series of podcasts. Section Editor David Gozal interviews Walter McNicholas (St Vincent’s University Hospital and University College Dublin, Ireland) about a report by an ad hoc working group of the Sleep Disordered Breathing Group of the European Respiratory Society and the European Sleep Research Society.

As part of the May issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy chief editor James Chalmers interviews Marc Humbert (Université Paris-Sud, Faculté de Médecine, Université Paris-Saclay, and AP-HP, Service de Pneumologie, Hôpital Bicêtre, Le Kremlin-Bicêtre, and INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France) about omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count.

As part of the April issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Martin Kolb interviews Andreas von Leupoldt (University of Leuven, Belgium) and Thomas Similowski (Sorbonne Universités and Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Paris, France) about how observing dyspnoea in others elicits dyspnoea, negative affect and brain responses.

As part of the March issue, the European Respiratory Journal presents the latest in its series of podcasts. To mark World TB Day, chief editor Martin Kolb interviews section editor Giovanni Battista Migliori about the following articles. ---- Borisov SE, Dheda K, Enwerem M, et al. Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study. Eur Respir J 2017; 49: 1700387. Cabibbe AM, Sotgiu G, Izco S, et al. Genotypic and phenotypic M. tuberculosis resistance: guiding clinicians to prescribe the correct regimens. Eur Respir J 2017; 50: 1702292. Falzon D, Schünemann HJ, Harausz E, et al. World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update. Eur Respir J 2017; 49: 1602308. Guglielmetti L, Jaspard M, Le Dû D, et al. Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis. Eur Respir J 2017; 49: 1601799. Miotto P, Tessema B, Tagliani E, et al. A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis. Eur Respir J 2017; 50: 1701354. Pontali E, Sotgiu G, Tiberi S, et al. Cardiac safety of bedaquiline: a systematic and critical analysis of the evidence. Eur Respir J 2017; 50: 1701462. Van der Werf MJ, Hollo V, Ködmön C, et al. Eligibility for shorter treatment of multidrug-resistant tuberculosis in the European Union. Eur Respir J 2017; 49: 1601992.

As part of the February issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Martin Kolb interviews Jørgen Vestbo (The University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK) about the important difference between standard efficacy trials and real-world effectiveness trials such as the Salford Lung Study.

As part of the January issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy chief editor James Chalmers interviews the Anthony De Soyza (Newcastle University, Newcastle, UK) and Timothy Aksamit (Mayo Clinic, Rochester, MN, USA) about the RESPIRE1 and RESPIRE2 trials of ciprofloxacin in non-cystic fibrosis bronchiectasis. These two global phase III trials enrolled a total of 937 and test two dosing regimens tested (identical dose). The range of treatment estimates favours use of a ciprofloxacin dry powder inhaler (DPI), which was overall, well tolerated, with high compliance and an excellent safety profile. The ciprofloxacin DPI 14-day regimen gave a 144-day delay in the to time to first exacerbation and a 25% reduction in the frequency of exacerbations, and the 28-day regimen gave a 138-day delay in to time to first exacerbation and a 28% reduction in frequency of exacerbations.

As part of the December issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert interviews the incoming Chief Editor Martin Kolb and Deputy Chief Editor James Chalmers about the future of the ERJ, and reflects on his own time as Chief Editor.

As part of the November issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the ERS statement on the diagnosis and treatment of pulmonary disease caused by α1-antitrypsin deficiency with Task Force chairs Marc Miravitlles (Hospital Universitari Vall d’Hebron, Barcelona, Spain) and Robert A. Stockley (Queen Elizabeth Hospital, Birmingham, UK).

As part of the October issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the lessons learned from clinical trials in idiopathic pulmonary fibrosis over the past 25 years with Prof. Ganesh Raghu from the University of Washington, Seattle, WA, USA.

As part of the September issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the publication of the results of a survey of patients with severe asthma with Prof. Helen K. Reddel from the University of Sydney, Sydney, and the NHMRC Centre for Research Excellence in Severe Asthma, Newcastle, Australia.

As part of the August issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the publication of the results of a trial of fevipiprant, an oral prostaglandin in DP2 receptor (CRTh2) antagonist, in allergic asthma that is not controlled by low-dose inhaled corticosteroids with Prof. Eric D. Bateman from the University of Cape Town, South Africa.